Skip to main content
Premium Trial:

Request an Annual Quote

Galapagos in Antiviral Discovery Collaboration with Boehringer Ingelheim

NEW YORK, Nov. 11 (GenomeWeb News) - Galapagos Genomics said today that it has entered into a collaboration with Boehringer Ingelheim in the field of antiviral discovery research.

Boehringer Ingelheim will use Galapagos' SilenceSelect platform - a collection of adenoviruses with siRNA-based knockdown sequences targeting over 4,000 human genes -- to perform a genome-wide screen for all drugable genes that influence viral replication in human cells, Galapagos said.

Galapagos said it will receive up-front technology access fees and will be eligible for further license fees during the program. Further financial terms were not disclosed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.